Navigation Links
Smokers Remain Unaware of the Health Effects of Smoking, New Survey Finds
Date:11/13/2007

oduct label.(1) Using the recommended amount of NRT maximizes

the efficacy of these products.

"The survey reveals that when smokers try quitting with NRT they do not use enough of it or use it for as long as directed on the products label," said Bill Slivka, President Smoking Control, GlaxoSmithKline Consumer Healthcare. "Study after study shows that, when used correctly, these products double a smoker's chances of quitting versus cold turkey.(7) The reality is that most smokers need some type of support when quitting smoking."

While research shows the majority of smokers try to quit "cold turkey," on any given quit attempt, only 3-5 percent of smokers who quit cold turkey are successful long-term.(8) Tools for cessation such as NRTs, social support, and counseling have been proven to greatly increase the chances of a successful quit attempt.(9) But the survey revealed that almost three-quarters (72 percent) of smokers surveyed believe that quitting is "just a matter of will power." (1) In reality, many smokers need support to address the addiction to nicotine and smoking. Smokers making a quit attempt should utilize resources such as counseling opportunities to help understand what to expect and how to handle the tough situations when quitting, and also consider safe and effective stop-smoking products.

NRT products such as the gum, patch and lozenge are among the first-line treatments recommended for all smokers and when used as directed, can double a smoker's chances of quitting versus cold turkey.(7) In fact, new research published by Thorax confirms NRT helps "real-world" smokers quit by doubling the odds of successfully quitting long-term and supports the findings of more than 100 randomized clinical trials.(10) NRT is extensively proven to significantly reduce cravings and other withdrawal symptoms during quitting, allowing smokers to focus on behavior change.(11) Data from more than 100 clinical trials involving more than 35,000 s
'/>"/>

SOURCE American Legacy Foundation; GlaxoSmithKline ConsumerHealthcare
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Teens who see more smoking in movies may have increased risk of becoming established smokers
2. Smokers More Likely to Develop Dementia
3. Help is Available for Smokers Who Want to Quit as Minnesotas Smoke-Free Law Takes Effect Oct. 1
4. First Puff Can Turn Kids Into Smokers: Study
5. Statins reduce loss of function, keeping old lungs young - even in smokers
6. Blood Test Catches Secret Smokers
7. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
8. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
9. Colonoscopy Remains the Most Effective Screening Option for Colon Cancer
10. Pelosi: We Remain Committed to Making SCHIP Into Law - With or Without the Presidents Support
11. The Physical Therapy Profession Remains in High Demand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 Punzoné , the first line ... has a lot to celebrate this month. October marks Italian ... achievements and contributions of Americans of Italian heritage and Italians ... today it shares its favorite Italian cocktails and encourages everyone ... - even if it is only in a glass. ...
(Date:10/20/2014)... Spring, Maryland, USA (PRWEB) October 20, 2014 ... or to track interventions? Here comes a wonderful app ... mobile app development company helped its client ... Intervention more efficiently. The app is designed for iOS ... and iPod touch. This app is optimized for iPhone ...
(Date:10/19/2014)... 20, 2014 The leading review ... http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the best Dedicated ... for those who want to buy high quality ... , The IT manager of Top10BestSEOHosting.com says, “We ... recommended suppliers for everyone. A lot of the ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 Dr. Babatunde ... Fund, welcomes news of a ceasefire agreement that is ... than 200 girls who were kidnapped from the north-eastern ... languished in captivity long enough, and it is high ... communities," stated Dr. Osotimehin. , "We owe it to ...
(Date:10/19/2014)... October 20, 2014 Having been working in ... good knowledge of customer needs. According to James, one of ... with dazzling sequins, or with high-low skirts that add beauty ... huge demand. Recently, LunaDress has unveiled its new selection of ... fact, the company’s brand new items are available in over ...
Breaking Medicine News(10 mins):Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2
... at Facility, PLANO, Texas, Dec. 7 The ... Dallas will have a safer environment,thanks to the Senior ... ViewPoint Bank is funding the program through,the Senior Housing ... in the nation,s senior housing facilities., "Crime against ...
... CHAPEL HILL, N.C., Dec. 7 A recent ... readiness for launch by a non-New,Product Introduction team ... launches. This study, "Ensuring a Successful New Product ... executives,with the knowledge and data to optimize their ...
... Free, accurate,information on many neurological disorders is ... the National Institute of Neurological,Disorders and Stroke ... Health,(NIH). The website is available at espanol.ninds.nih.gov., ... website includes publications on,stroke, dementia, Parkinson,s disease, ...
... role in liver treatment , FRIDAY, Dec. 7 (HealthDay ... alcoholics with cirrhosis of the liver, says an Italian ... . , The study included 84 alcohol-dependent patients with ... or a placebo (42 patients). Total alcohol abstinence and ...
... be passed on to nursing infants, rat study shows , , ... mechanism by which a chemical known as perchlorate can collect ... newborns. , Used since the 1940s to manufacture explosives and ... water and food supply, experts say. , And high concentrations ...
... 7 Transcept Pharmaceuticals,Inc. today announced that Glenn A. ... expert panel on "Drug Development in a,Changed Environment" at ... New York Hotel at Times Square on Thursday, December ... panel will be moderated by Ken Trbovich, Vice,President, Capital ...
Cached Medicine News:Health News:ViewPoint Bank Funds Senior Crimestoppers Program at Meadows Health and Rehab Center in Dallas 2Health News:Best Practice Database: Complimentary Excerpt of 'Ensuring a Successful New Product Launch Through Effective Processes and Authority Roles' 2Health News:Baclofen Aids Abstinence in Alcoholics With Cirrhosis 2Health News:Environmental Toxin Collects in Breast Milk 2Health News:Environmental Toxin Collects in Breast Milk 3Health News:Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference 2
(Date:10/17/2014)... October 17, 2014 ... http://www.researchandmarkets.com/research/rxznjk/micro_market ) has announced the addition ... North American Automated External Defibrillators (AED) ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,The report North American ... the market of devices based upon ...
(Date:10/17/2014)... , October 17, 2014 ... Pharmaceuticals Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... CPRX). Free research on these five companies can be ... markets on Thursday, October 16, 2014, ended on a ...
(Date:10/17/2014)... -- Talyst, a market leader in pharmacy automation will be ... Nashville, TN. The company will be ... onsite, remote medication dispensing. Talyst,s InSite ... securely dispense medication onsite, on demand. Remote dispensing cuts ... the correct medication gets to the correct patient in ...
Breaking Medicine Technology:Micro Market Monitor : North American Automated External Defibrillators (AED) Market 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Talyst Exhibits at LeadingAge Annual Meeting 2
... Reportlinker.com announces that a new ... its catalogue: ... to 2017 - Multiple Sclerosis, Major ... Half the Market Value in 2010 ...
... events organiser UBM Live , a division of UBM ... event, CPhI South East Asia to cater to the pharmaceutical ... 12 May at the Jakarta International Expo in Indonesia. The ... is being introduced to offer a meeting place for pharmaceutical ...
Cached Medicine Technology:Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 2Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 3Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 4Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 5Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 6Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 7Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 8Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 9Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 10Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 11Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 12Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 13Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 14Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 15Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 16Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 17Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 18Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 19Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010 20CPhI Global Portfolio Expands into South East Asia 2
Toothed grasping forcep....
Bateman pituitary forceps, round cup, 5 mm bite, fenestrated crocodile jaws, 150 mm effective....
Micro cup pituitary forceps, semi-malleable shafts....
Bayonet Kerrison Rongeur, ceramic ejector, 9.5 length 40 Fwd, 6.5 working length 165 mm....
Medicine Products: